
IFRXInflaRx N.V.
Slide 1 of 3 



Company Overview
Name
InflaRx N.V.
52W High
$2.82
52W Low
$0.71
Market Cap
$53.8M
Dividend Yield
0%
Price/earnings
-0.8074
P/E
-0.8074
Tags
Biotechnology
Health Technology
Manufacturing
Pharmaceutical Preparation Manufacturing
Dividends
No dividend
Sentiment
Score
Mixed
56
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$171.6K
Operating Revenue
$171.6K
Total Gross Profit
$-3.3M
Total Operating Income
$-60.3M
Net Income
$-47.7M
EV to EBITDA
$0.00
EV to Revenue
$2,225.23
Price to Book value
$0.00
Price to Earnings
$0.00
Additional Data
Selling, General & Admin Expense
$13.5M
Marketing Expense
$7M
Research & Development Expense
$36.6M
Other Operating Expenses / (Income)
$307.00
Total Operating Expenses
$-57.1M
Interest Expense
$-21.4K
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5 



Company Overview
Name
InflaRx N.V.
52W High
$2.82
52W Low
$0.71
Market Cap
$53.8M
Dividend Yield
0%
Price/earnings
-0.8074
P/E
-0.8074
Tags
Biotechnology
Health Technology
Manufacturing
Pharmaceutical Preparation Manufacturing
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Mixed
56
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$171.6K
Operating Revenue
$171.6K
Total Gross Profit
$-3.3M
Total Operating Income
$-60.3M
Net Income
$-47.7M
EV to EBITDA
$0.00
EV to Revenue
$2,225.23
Price to Book value
$0.00
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$13.5M
Marketing Expense
$7M
Research & Development Expense
$36.6M
Other Operating Expenses / (Income)
$307.00
Total Operating Expenses
$-57.1M
Interest Expense
$-21.4K
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Niels C. Riedemann
Location
N/A, Germany
Exchange
Nasdaq
Website
https://inflarx.de
Summary
InflaRx N.
Company Info
CEO
Niels C. Riedemann
Location
N/A, Germany
Exchange
Nasdaq
Website
https://inflarx.de
Summary
InflaRx N.